Brief: Biosynex Extends Tender Offer Period On Shares Of Chembio Diagnostics
March 15 (Reuters) - Biosynex SA ALBIO.PA :
* EXTENSION OF THE TENDER OFFER PERIOD ON THE SHARES OF
CHEMBIO
DIAGNOSTICS INC
* EXTENSION UNTIL MARCH 28, 2023 AT 6 PM EST
* ALL OTHER TERMS AND CONDITIONS OF THE TENDER OFFER REMAIN
UNCHANGED
Source text for Eikon: ID:nEQ5v5wlBa
Further company coverage: ALBIO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Biosynex SA
See all newsBrief: Biosynex FY Revenue Down To EUR 93.1 Million
Brief: Biosynex Announces Completion Of Merger-Absorption Of Theradiag
Brief: Biosynex Q3 Group Revenue Rises To EUR 24.4 Mln
Brief: Biosynex Announces Its Subsidiary Procisedx Acquires Two U.S. Patents
Brief: Biosynex's Procisedx Obtains First FDA Approvals